04 Aug '23 - 08 Aug '23
₹14,820 / 1 Lots (20 Shares)
₹705 - ₹741
₹192,660 / 13 Lots (260 Shares)
Investor category and sub categoryQualified Institutional Buyers | Non-Institutional Investors | Retail Individual Investors | Employees |
Concord Biotech IPO Dates
Important dates with respect to IPO allotment and listing
IPO Opening Date
Aug 4, 2023
IPO Closing Date
Aug 8, 2023
Basis of Allotment
Aug 11, 2023
Initiation of Refunds
Aug 14, 2023
Credit of Shares to Demat Account
Aug 17, 2023
IPO Listing Date
Aug 18, 2023
UPI Mandatory Expiry Date
Aug 8, 2023
Concord Biotech IPO Subscription Details
Day 1Aug 4, 2023
Concord Biotech IPO Subscription Live Status
|Investor Category||Subscription (Times)|
|Qualified Institutions Buyers||0.00|
About Concord Biotech Ltd
Concord Biopharma started its operations in 2016 and is a leading Indian pharma company engaged in manufacturing selected fermentation-based APIs (Active Pharmaceutical Ingredients) for immunosuppressants and oncology drugs. Concord Biopharma exports to more than 70 countries in the USA, Europe, Japan, Nepal, Mexico, Indonesia, Thailand, Ecuador, Kenya, Singapore, Paraguay, and India. It has established a successful, backwards-integrated, scalable business model. The company is one of the few companies to produce six fermentation-based immunosuppressant APIs.
Concord Biotech is expanding to include anti-fungal and oncology drug APIs.
Concord Biotech Ltd IPO Details
Concord Biotech is a 100% offer for sale worth ₹1,551.00 crore. The issue comprises 20,925,652 shares and is priced at ₹705 to ₹741 per share. Retail investors can bid for the Concord Biotech Limited IPO, which will open on August 4, 2023. Concord Biotech Limited’s IPO will list on the BSE and NSE exchanges on August 18, 2023.
Concord Biotech Ltd IPO Objective
- To achieve the benefits of listing on the stock exchanges
- To carry out the offer for sale of up to 20,925,652 shares
Noteworthy Highlights Of Concord Biotech Ltd
- As of March 31, 2022, the annual installed capacity for formulation manufacturing was 522.64 million units.
- The company caters to 200 customers in 70 countries and offers a diversified product portfolio of 27 brands across immunosuppressant API, nephrology, anti-fungal, anti-infective, oncology, and critical care drugs APIs.
Other listed players in the segment recognised by Concord Biotech Ltd are Divi’s Laboratories, Suven Pharmaceuticals, Laurus Labs, and Shilpa Medicare.
Concord Biotech Ltd Company Financials
|Particulars||March 31, 2023 (₹ in million)||March 31, 2022 (₹ in million)||March 31, 2021 (₹ in million)|
|Profit After Tax (PAT)||2,400.84||1,749.29||2,348.87|
|Earnings Per Share||22.95||16.72||22.45|
Know before investing
The net worth of the company increased from ₹9,993.73 million on March 31, 2021, to ₹12,900.01 million on March 31, 2023.
Concord Biopharma is a leader in its segment with a 20% market share in 2022, in terms of volume.
Concord Biotech’s revenue is dependent on limited customers and any interruption in the client’s demand can adversely impact the company’s revenue.
If the company is not able to obtain trademarks and patents for their products, the business can get impacted.
Login to Angel One App / Website & click on IPO
Select desired IPO & tap on "Apply"
Enter UPI ID, set quantity/price & submit
Accept mandate on the UPI app to complete the process
Login to Angel One App / Website
Choose IPO section on Home Page
Click IPO Orders
Chose the IPO application you want to view the status for
Concord Biotech Ltd IPO FAQs
The Concord Biotech Ltd IPO is 100% Offer for Sale IPO worth ₹1,551 crore. The issue comprises 20,925,652 shares and is priced at ₹705 to ₹741 per share. The IPO will open on August 4, 2023.
The Basis of Allotment will happen on Friday, August 11, 2023.
The IPO subscription window will open on Friday, August 04, 2023.
Retail investors can apply for a minimum of one lot, which consists of 20 shares.
Concord Biotech Ltd IPO will list on the BSE and NSE exchanges on Friday, August 18, 2023.
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app
- Validate with an OTP
- Enter your application number, DP ID, and PAN number into the app
- Click on ‘Submit’
Listing gains cannot be ascertained before the listing of the IPO on the stock exchange, which is Friday, August 18, 2023, for Concord Biotech Ltd.
The bank will only block the amount initially in your account. Under the new system, the money isn’t debited until the stocks are allotted to you.
You must complete the payment process by logging in to your UPI handle and approving the payment mandate.
You can submit only one application using your PAN card.